Program to provide universal access to Mifegymiso04 April 2017
FREDERICTON (GNB) – The provincial government will introduce a program to provide universal access to Mifegymiso, commonly referred to as the abortion pill.
“Your government has eliminated barriers to reproductive health that were in place for three decades, and is committed to doing more,” said Health Minister Victor Boudreau. “By making Mifegymiso available free of charge for all New Brunswick women, our government is ensuring that financial barriers do not stand in the way of a woman’s right to choose.”
Mifegymiso is a combination drug product approved for the medical termination of a pregnancy up to 49 days. It was authorized by Health Canada in July 2015 and became available on the market in January.
Mifegymiso was approved for use in Canada under the following conditions:
- it must be prescribed by a physician who has completed a training course and is registered with the manufacturer;
- an ultrasound is required to confirm the gestational age;
- it cannot be prescribed beyond the gestational age of 49 days; and
- it can only be provided to the patient by a physician.
In the coming months, the Department of Health will introduce a program to ensure that any woman who possesses a valid Medicare card will be eligible to receive Mifegymiso free of charge.
“As Mifegymiso becomes more widely available throughout the country and New Brunswick, we commit to working with physicians, as well as pharmaceutical distributors, to ensure timely and universal coverage for all New Brunswick women,” said Boudreau.04-04-17